Our Company
REM Analytics SA is a biotechnology company spun out from EPFL in 2020, headquartered at the BioArk in Monthey, Switzerland.
What We Do
At REM Analytics we develop high-resolution microbial assays for applications where precision, specificity and reproducibility are absolutely key to answer critical biological questions.
Our ATGC platform provides species-to-strain-level quantification of microorganisms in complex samples, supporting product development, clinical research and agricultural applications.
Technology Foundation
Our proprietary approach combines Cycling Temperature Capillary Electrophoresis (CTCE) with curated reference databases and specialized bioinformatics, delivering quantitative precision and discrimination of closely related organisms.
Validated Applications
We have developed assay panels integrated in commercial products and European research programs.
Applications area
Women’s health, gut microbiome, soil microbiomes, clinical microbiology
commercial products
YoniSolutions, Elements
EU research consortia
Horizon Europe projects
Research Partnerships
Since our foundation, we have collaborated with leading institutions through European and Swiss innovation programs.
Active collaboration in European research consortia advancing microbiome science
Swiss innovation support for technology development and validation
EIT Food, MassChallenge, Plug-and-Play acceleration and partnership programs
Collaborations with academic institutions and biotechnology companies
Our Mission
Advance microbiome and clinical microbiology research through measurements precise enough to stratify individuals, validate interventions and guide product development.
“The strength of science lies in the precision of its measurements
— and we provide that precision where it matters most.“
Ready to Learn More?
Discover how REM Analytics can support your research or product development